About
Medical Devices for Breathing
Areas of Focus
Categories
Uncategorized Medical DeviceMidwest
Team (8)
Dennis Wahr, M.D.
President & CEO
Nuvaira
executive
Doug Sisson
Chief Investment Officer
Nuvaira
team_member
Geoffrey Duyk
Vice Chairman
Nuvaira
board_chair
John Carline
Sr. Director, Regulatory & Quality
Nuvaira
team_member
Lisa Flaherty
Sr. Vice President, Global Market Development
Nuvaira
executive
Philip Johnson, Ph.D.
Vice President, Science, Clinical and R&D
Nuvaira
executive
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,031
By Phase
PHASE3: 1NA: 3PHASE1: 2
By Status
COMPLETED: 3NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07051707Lead Sponsor
Evaluating the Safety and Efficacy of TLD in Patients With COPD
PHASE3Not yet recruiting
400 participants
Started: Sep 1, 2025 · Completed: Dec 31, 2029
NCT03639051Lead Sponsor
Evaluation of the Safety and Efficacy of TLD in Patients with COPD
NAActive, not recruiting
464 participants
Started: May 23, 2019 · Completed: Sep 30, 2028
NCT03213080Lead Sponsor
Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population
N/AWithdrawn
Started: Dec 31, 2017 · Completed: Sep 30, 2021
NCT02872298Lead Sponsor
Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma
NATerminated
2 participants
Started: Dec 22, 2017 · Completed: Apr 6, 2020
NCT02058459Lead Sponsor
Targeted Lung Denervation for Patients With Moderate to Severe COPD
NACompleted
128 participants
Started: Aug 4, 2014 · Completed: Jun 16, 2020
Locations (1)
Headquarters
Minneapolis, MN, United States
Map
Loading map...